RECENTLY PUBLISHED

THE AMERICAN HEART ASSOCIATION/AMERICAN STROKE ASSOCIATION (AHA/ASA) RELEASED UPDATED GUIDELINES ON SECONDARY STROKE PREVENTION, WITH A RECOMMENDATION FOR PFO CLOSURE.

The guidelines state that “it is now considered reasonable to close patent foramen ovale percutaneously in selected patients: those with younger age with nonlacunar stroke or no other cause at any age.”

MAT-2107556 v1.0 | Item approved for Global use.
Skip to main content
Visit HCP site
United States

PFO Closure and Stroke Prevention

About procedure i Stock 486858785

Get closure and peace-of-mind with the Amplatzer™ Talisman™ PFO Occluder

Fear of having another stroke can be overwhelming. Especially when you don’t know what caused your first stroke and you know you are at risk for another stroke. Closing your patent foramen ovale (PFO) with the Amplatzer Talisman PFO Occluder is proven to reduce the risk of having another stroke. Guidelines from the American Academy of Neurology and the American Heart Association/American Stroke Association support PFO closure for carefully selected patients.

Occluder stroke risk tal 2x

Proven to lower the risk of recurrent stroke

Multiple studies have shown that in patients who have had the PFO closure procedure along with medicine that reduces blood clots, the relative risk of having another stroke was reduced 59% compared to patients who only received medicine.¹

The Amplatzer Talisman PFO Occluder has been shown to be far more effective at lowering stroke risk than medicine alone.2

More than 180,000 patients and thousands of physicians around the world have chosen the Amplatzer Talisman PFO Occluder to reduce stroke risk.3

How is the Amplatzer Talisman PFO Occluder implanted?

Find out what to expect during and after this minimally invasive procedure.

Learn about the procedure
References
  1. Messé SR, Gronseth GS, Kent DM, et al. Practice Advisory update summary: Patent foramen ovale and secondary stroke prevention. Neurology. 2020;94:876-885.
  2. Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377:1022-32.
  3. Abbott Data on file.
MAT-2002549 v4.0 | Item approved for U.S. use only.

You are about to leave pfostroke.com

Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

Sign up for information on PFO and stroke.

If you or a loved one have a PFO and have experienced a stroke, we have resources you may find helpful.

Sign up Receive more information on reducing risk of another stroke REGISTER NOW